These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 4468426)
21. [Effect of immunosuppressive agents on systemic lupus erythematosus]. Hashimoto H Ryumachi; 1976 May; 16(2):174-83. PubMed ID: 959906 [No Abstract] [Full Text] [Related]
22. [Immunosuppressive therapy of collagen diseases]. Tsubura E Naika; 1970; 25(5):888-95. PubMed ID: 4912158 [No Abstract] [Full Text] [Related]
23. Immunosuppressive therapy in management of non-malignant disease. Fennelly JJ; Fitzgerald MX; Fitzgerald O J Ir Med Assoc; 1970 Apr; 63(394):141-6. PubMed ID: 5418154 [No Abstract] [Full Text] [Related]
24. [Corticosteroid therapy of various systemic diseases (non-neoplastic, noninfectious)]. Sternon J; Decaux G; Nève P Rev Med Brux; 1991 May; 12(5):179-85. PubMed ID: 2057665 [TBL] [Abstract][Full Text] [Related]
25. [Short report on the possibilities of an immunosuppressive treatment in pulmonary diseases]. Morawetz F Wien Med Wochenschr; 1974 Oct; 124(40):584-6. PubMed ID: 4139821 [No Abstract] [Full Text] [Related]
26. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis]. Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572 [No Abstract] [Full Text] [Related]
27. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases]. Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047 [No Abstract] [Full Text] [Related]
32. The clinical use of immunosuppressive drugs. Forbes IJ Med J Aust; 1973 Apr; 1(15):749-52. PubMed ID: 4707372 [No Abstract] [Full Text] [Related]
33. [Thalidomide--a new prospective therapy in rheumatology and transplantation]. Pałgan K; Pałgan I; Dziedziczko A Wiad Lek; 2003; 56(11-12):574-6. PubMed ID: 15058168 [TBL] [Abstract][Full Text] [Related]
34. [The mode of action of immunosuppressors]. Bach JF Actual Pharmacol (Paris); 1974; 27():23-44. PubMed ID: 4620128 [No Abstract] [Full Text] [Related]
35. Immunosuppressive drugs in dermatology--benefits and threats. Kowal A; Warmińska J; Krasowska D Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):14-21. PubMed ID: 15323159 [TBL] [Abstract][Full Text] [Related]
36. [Regional intra-articular treatment of rheumatoid arthritis with different drugs, especially with immunosuppressive agents]. Anastasescu G; Marin D Med Interna (Bucur); 1969 May; 21(5):597-600. PubMed ID: 5344552 [No Abstract] [Full Text] [Related]
37. Corticosteroid therapy of the collagen vascular disorders. Yount WJ; Utsinger PD; Puritz EM; Ortbals DW Med Clin North Am; 1973 Sep; 57(5):1343-55. PubMed ID: 4593203 [No Abstract] [Full Text] [Related]
38. [Treatment of lupus erythematosus disseminatus]. Kahn MF; de Sèze M; Guérin B Therapeutique; 1971 May; 47(5):459-63. PubMed ID: 5562480 [No Abstract] [Full Text] [Related]
39. [Immunology of rheumatoid arthritis from a clinical viewpoint]. Keitel W Beitr Orthop Traumatol; 1971; 18(2):106-12. PubMed ID: 4995856 [No Abstract] [Full Text] [Related]
40. [Our experiences with immunosuppressive therapy of rheumatic diseases]. Malesević M; Andelić M; Nakicević M; Pasić I Med Arh; 1974 Jan; 28(0):suppl:65-9. PubMed ID: 4600455 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]